Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,268 GBX | +0.16% | +3.59% | +6.30% |
Apr. 23 | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
Apr. 23 | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC